InnoTherapy Financials
| 246960 Stock | KRW 8,430 130.00 1.57% |
InnoTherapy |
Understanding current and past InnoTherapy Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of InnoTherapy's financial statements are interrelated, with each one affecting the others. For example, an increase in InnoTherapy's assets may result in an increase in income on the income statement.
Please note, the presentation of InnoTherapy's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, InnoTherapy's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of InnoTherapy's management manipulating its earnings.
InnoTherapy Stock Summary
InnoTherapy competes with Kolon Life, JETEMA, Aminologics CoLtd, Daihan Pharmaceutical, and HLB Pharmaceutical. InnoTherapy, Inc., engages in the development and sale of medical sealant products in South Korea. The company was founded in 2010 and is headquartered in Seoul, South Korea. InnoTherapy is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| ISIN | KR7246960009 |
| Business Address | 401, ACE Hitech |
| Industry | Pharmaceuticals |
| Benchmark | Dow Jones Industrial |
| Website | www.innotherapy.com |
| Phone | 82 2 6959 1338 |
| Currency | KRW - South Korean Won |
You should never invest in InnoTherapy without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of InnoTherapy Stock, because this is throwing your money away. Analyzing the key information contained in InnoTherapy's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
InnoTherapy Key Financial Ratios
InnoTherapy's financial ratios allow both analysts and investors to convert raw data from InnoTherapy's financial statements into concise, actionable information that can be used to evaluate the performance of InnoTherapy over time and compare it to other companies across industries.| Return On Equity | -66.34 | |||
| Return On Asset | -0.13 | |||
| Number Of Employees | 26 | |||
| Beta | 1.49 | |||
| Z Score | 1.2 |
InnoTherapy Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining InnoTherapy's current stock value. Our valuation model uses many indicators to compare InnoTherapy value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InnoTherapy competition to find correlations between indicators driving InnoTherapy's intrinsic value. More Info.InnoTherapy is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value InnoTherapy by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for InnoTherapy's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.InnoTherapy Systematic Risk
InnoTherapy's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. InnoTherapy volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on InnoTherapy correlated with the market. If Beta is less than 0 InnoTherapy generally moves in the opposite direction as compared to the market. If InnoTherapy Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one InnoTherapy is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of InnoTherapy is generally in the same direction as the market. If Beta > 1 InnoTherapy moves generally in the same direction as, but more than the movement of the benchmark.
InnoTherapy Thematic Clasifications
InnoTherapy is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
| Health Management | View |
InnoTherapy November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of InnoTherapy help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InnoTherapy. We use our internally-developed statistical techniques to arrive at the intrinsic value of InnoTherapy based on widely used predictive technical indicators. In general, we focus on analyzing InnoTherapy Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InnoTherapy's daily price indicators and compare them against related drivers.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 7.15 | |||
| Value At Risk | (2.30) | |||
| Potential Upside | 2.78 |
Complementary Tools for InnoTherapy Stock analysis
When running InnoTherapy's price analysis, check to measure InnoTherapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnoTherapy is operating at the current time. Most of InnoTherapy's value examination focuses on studying past and present price action to predict the probability of InnoTherapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnoTherapy's price. Additionally, you may evaluate how the addition of InnoTherapy to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |